2 results
Approved WMOCompleted
The hypothesis of this study is that the regular topical application of Oxofulleram in patients with rosacea results in a reduction of the clinical symptoms.
Approved WMOCompleted
Primary Objective:• To assess and compare efficacy of sacituzumab govitecan to TPC as measured by progression free survival (PFS) as determined by blinded independent central review (BICR) using Response Evaluation Criteria in Solid Tumors Version 1…